News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,249 Results
Type
Article (299)
Press Release (950)
Section
Business (423)
Deals (25)
Drug Development (469)
Employer Resources (1)
FDA (47)
Job Trends (34)
News (744)
Policy (139)
Tag
Academia (13)
Alliances (90)
Antibody-drug conjugate (ADC) (1)
Approvals (41)
Bankruptcy (1)
Best Places to Work (24)
Cancer (1)
Cardiovascular disease (1)
Career advice (1)
Cell therapy (2)
Clinical research (228)
Collaboration (2)
COVID-19 (211)
Data (3)
Diabetes (1)
Diagnostics (28)
Drug pricing (1)
Drug shortages (1)
Earnings (173)
Editorial (2)
Employer resources (1)
Events (179)
Executive appointments (2)
FDA (48)
Funding (1)
Gene editing (1)
GLP-1 (9)
Government (74)
Healthcare (52)
Infectious disease (212)
Inflation Reduction Act (1)
Influenza (3)
IPO (13)
Job creations (8)
Layoffs (3)
Leadership (1)
Legal (7)
Manufacturing (4)
Medical device (11)
Medtech (11)
Mergers & acquisitions (13)
Metabolic disorders (7)
Neuroscience (1)
NextGen: Class of 2025 (9)
Non-profit (6)
Obesity (4)
Opinion (1)
People (135)
Phase I (110)
Phase II (142)
Phase III (111)
Pipeline (2)
Podcasts (3)
Policy (5)
Preclinical (66)
Press Release (1)
Rare diseases (3)
Real estate (12)
Recruiting (1)
Regulatory (82)
Research institute (17)
Sickle cell disease (1)
Special edition (1)
Startups (5)
Supply chain (2)
The Weekly (3)
United States (30)
Vaccines (63)
Weight loss (5)
Date
Today (1)
Last 7 days (3)
Last 30 days (7)
Last 365 days (60)
2025 (18)
2024 (51)
2023 (68)
2022 (152)
2021 (194)
2020 (194)
2019 (23)
2018 (18)
2017 (35)
2016 (42)
2015 (50)
2014 (50)
2013 (35)
2012 (40)
2011 (40)
2010 (46)
Location
Africa (4)
Asia (74)
Australia (9)
Canada (1)
Europe (107)
Florida (1)
Maryland (22)
Massachusetts (1)
New Jersey (1)
New York (3)
Pennsylvania (1)
South America (2)
1,249 Results for "novavax".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
FDA Misses Review Deadline for Novavax’s COVID-19 Shot, Days After Marks’ Resignation
The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1, but the agency’s principal deputy commissioner intervened.
April 3, 2025
·
2 min read
·
Tristan Manalac
COVID-19
Novavax Applies Lessons Learned From Turbulent COVID-19 Experience
As sales of its COVID vaccine plummet, Novavax is looking ahead toward other novel vaccines, brought to market with the help of the company’s pharma partners—something it opted not to do as the pandemic swept the globe in 2020.
March 10, 2025
·
6 min read
·
Heather McKenzie
Vaccines
Two Years Into Novavax Reset, CEO Jacobs Hunts for Silver Linings
After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs says the company is at a pivot point.
January 28, 2025
·
6 min read
·
Annalee Armstrong
FDA
UPDATE: FDA Lifts Clinical Hold on Novavax’s COVID/Flu Vaccine Candidates, Clears Phase III Trial
Novavax’s shared jumped 12% in pre-market trading on the news.
November 11, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Novavax to Participate in Upcoming March 2025 Investor Conferences
February 28, 2025
·
1 min read
Press Releases
Novavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
February 27, 2025
·
17 min read
COVID-19
Novavax Catches Up to Competitors With FDA Approval for Updated COVID-19 Boosters
Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a recombinant version of the virus’ spike protein to elicit protection.
September 3, 2024
·
2 min read
·
Tristan Manalac
BioCapital
Novavax to Participate in 2024 Jefferies Global Healthcare Conference
Novavax, Inc. today announced it will participate in the 2024 Jefferies Global Healthcare Conference.
May 30, 2024
·
1 min read
Press Releases
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025
February 20, 2025
·
2 min read
BioCapital
Novavax to Participate in BofA Securities 2024 Health Care Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the BofA Securities 2024 Health Care Conference.
May 13, 2024
·
1 min read
1 of 125
Next
